Nucleic Vaccine Market
1 Study Coverage
1.1 Nucleic Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Nucleic Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Preventive Nucleic Vaccine
1.2.3 Therapeutic Nucleic Vaccine
1.3 Market by Application
1.3.1 Global Nucleic Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nucleic Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Nucleic Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Nucleic Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nucleic Vaccine Sales by Region
2.4.1 Global Nucleic Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Nucleic Vaccine by Region (2023-2028)
2.5 Global Nucleic Vaccine Revenue by Region
2.5.1 Global Nucleic Vaccine Revenue by Region (2017-2022)
2.5.2 Global Nucleic Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nucleic Vaccine Sales by Manufacturers
3.1.1 Global Top Nucleic Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Nucleic Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nucleic Vaccine in 2021
3.2 Global Nucleic Vaccine Revenue by Manufacturers
3.2.1 Global Nucleic Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Nucleic Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nucleic Vaccine Revenue in 2021
3.3 Global Nucleic Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nucleic Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nucleic Vaccine Sales by Type
4.1.1 Global Nucleic Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Nucleic Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Nucleic Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Nucleic Vaccine Revenue by Type
4.2.1 Global Nucleic Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Nucleic Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nucleic Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Nucleic Vaccine Price by Type
4.3.1 Global Nucleic Vaccine Price by Type (2017-2022)
4.3.2 Global Nucleic Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nucleic Vaccine Sales by Application
5.1.1 Global Nucleic Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Nucleic Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Nucleic Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Nucleic Vaccine Revenue by Application
5.2.1 Global Nucleic Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Nucleic Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nucleic Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Nucleic Vaccine Price by Application
5.3.1 Global Nucleic Vaccine Price by Application (2017-2022)
5.3.2 Global Nucleic Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nucleic Vaccine Market Size by Type
6.1.1 North America Nucleic Vaccine Sales by Type (2017-2028)
6.1.2 North America Nucleic Vaccine Revenue by Type (2017-2028)
6.2 North America Nucleic Vaccine Market Size by Application
6.2.1 North America Nucleic Vaccine Sales by Application (2017-2028)
6.2.2 North America Nucleic Vaccine Revenue by Application (2017-2028)
6.3 North America Nucleic Vaccine Market Size by Country
6.3.1 North America Nucleic Vaccine Sales by Country (2017-2028)
6.3.2 North America Nucleic Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Nucleic Vaccine Market Size by Type
7.1.1 Europe Nucleic Vaccine Sales by Type (2017-2028)
7.1.2 Europe Nucleic Vaccine Revenue by Type (2017-2028)
7.2 Europe Nucleic Vaccine Market Size by Application
7.2.1 Europe Nucleic Vaccine Sales by Application (2017-2028)
7.2.2 Europe Nucleic Vaccine Revenue by Application (2017-2028)
7.3 Europe Nucleic Vaccine Market Size by Country
7.3.1 Europe Nucleic Vaccine Sales by Country (2017-2028)
7.3.2 Europe Nucleic Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nucleic Vaccine Market Size by Type
8.1.1 Asia Pacific Nucleic Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Nucleic Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Nucleic Vaccine Market Size by Application
8.2.1 Asia Pacific Nucleic Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Nucleic Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Nucleic Vaccine Market Size by Region
8.3.1 Asia Pacific Nucleic Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Nucleic Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Nucleic Vaccine Market Size by Type
9.1.1 Latin America Nucleic Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Nucleic Vaccine Revenue by Type (2017-2028)
9.2 Latin America Nucleic Vaccine Market Size by Application
9.2.1 Latin America Nucleic Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Nucleic Vaccine Revenue by Application (2017-2028)
9.3 Latin America Nucleic Vaccine Market Size by Country
9.3.1 Latin America Nucleic Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Nucleic Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nucleic Vaccine Market Size by Type
10.1.1 Middle East and Africa Nucleic Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nucleic Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Nucleic Vaccine Market Size by Application
10.2.1 Middle East and Africa Nucleic Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nucleic Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Nucleic Vaccine Market Size by Country
10.3.1 Middle East and Africa Nucleic Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nucleic Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Moderna
11.1.1 Moderna Corporation Information
11.1.2 Moderna Overview
11.1.3 Moderna Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Moderna Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Moderna Recent Developments
11.2 CureVac
11.2.1 CureVac Corporation Information
11.2.2 CureVac Overview
11.2.3 CureVac Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CureVac Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CureVac Recent Developments
11.3 Inovio
11.3.1 Inovio Corporation Information
11.3.2 Inovio Overview
11.3.3 Inovio Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Inovio Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Inovio Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 GSK
11.5.1 GSK Corporation Information
11.5.2 GSK Overview
11.5.3 GSK Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GSK Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GSK Recent Developments
11.6 CNBG
11.6.1 CNBG Corporation Information
11.6.2 CNBG Overview
11.6.3 CNBG Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 CNBG Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CNBG Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Corporation Information
11.7.2 Hualan Bio Overview
11.7.3 Hualan Bio Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Hualan Bio Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hualan Bio Recent Developments
11.8 Zhifei Shengwu
11.8.1 Zhifei Shengwu Corporation Information
11.8.2 Zhifei Shengwu Overview
11.8.3 Zhifei Shengwu Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zhifei Shengwu Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhifei Shengwu Recent Developments
11.9 Liaoning Chengda
11.9.1 Liaoning Chengda Corporation Information
11.9.2 Liaoning Chengda Overview
11.9.3 Liaoning Chengda Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Liaoning Chengda Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Liaoning Chengda Recent Developments
11.10 BioKangtai
11.10.1 BioKangtai Corporation Information
11.10.2 BioKangtai Overview
11.10.3 BioKangtai Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 BioKangtai Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 BioKangtai Recent Developments
11.11 CanSinoBIO
11.11.1 CanSinoBIO Corporation Information
11.11.2 CanSinoBIO Overview
11.11.3 CanSinoBIO Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CanSinoBIO Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CanSinoBIO Recent Developments
11.12 Walvax Biotechnology
11.12.1 Walvax Biotechnology Corporation Information
11.12.2 Walvax Biotechnology Overview
11.12.3 Walvax Biotechnology Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Walvax Biotechnology Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Walvax Biotechnology Recent Developments
11.13 Fosun Pharma
11.13.1 Fosun Pharma Corporation Information
11.13.2 Fosun Pharma Overview
11.13.3 Fosun Pharma Nucleic Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Fosun Pharma Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Fosun Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nucleic Vaccine Industry Chain Analysis
12.2 Nucleic Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nucleic Vaccine Production Mode & Process
12.4 Nucleic Vaccine Sales and Marketing
12.4.1 Nucleic Vaccine Sales Channels
12.4.2 Nucleic Vaccine Distributors
12.5 Nucleic Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nucleic Vaccine Industry Trends
13.2 Nucleic Vaccine Market Drivers
13.3 Nucleic Vaccine Market Challenges
13.4 Nucleic Vaccine Market Restraints
14 Key Findings in The Global Nucleic Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Nucleic Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Preventive Nucleic Vaccine
Table 3. Major Manufacturers of Therapeutic Nucleic Vaccine
Table 4. Global Nucleic Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Nucleic Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Nucleic Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Nucleic Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Nucleic Vaccine Sales by Region (2023-2028) & (K Units)
Table 9. Global Nucleic Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Nucleic Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Nucleic Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Nucleic Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Nucleic Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Nucleic Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Nucleic Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Nucleic Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Nucleic Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Nucleic Vaccine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Nucleic Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Nucleic Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Vaccine as of 2021)
Table 21. Nucleic Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nucleic Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Nucleic Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nucleic Vaccine Sales by Type (2017-2022) & (K Units)
Table 26. Global Nucleic Vaccine Sales by Type (2023-2028) & (K Units)
Table 27. Global Nucleic Vaccine Sales Share by Type (2017-2022)
Table 28. Global Nucleic Vaccine Sales Share by Type (2023-2028)
Table 29. Global Nucleic Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Nucleic Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Nucleic Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Nucleic Vaccine Revenue Share by Type (2023-2028)
Table 33. Nucleic Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Nucleic Vaccine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Nucleic Vaccine Sales by Application (2017-2022) & (K Units)
Table 36. Global Nucleic Vaccine Sales by Application (2023-2028) & (K Units)
Table 37. Global Nucleic Vaccine Sales Share by Application (2017-2022)
Table 38. Global Nucleic Vaccine Sales Share by Application (2023-2028)
Table 39. Global Nucleic Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Nucleic Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Nucleic Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Nucleic Vaccine Revenue Share by Application (2023-2028)
Table 43. Nucleic Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Nucleic Vaccine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Nucleic Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. North America Nucleic Vaccine Sales by Type (2023-2028) & (K Units)
Table 47. North America Nucleic Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Nucleic Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Nucleic Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. North America Nucleic Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. North America Nucleic Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Nucleic Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Nucleic Vaccine Sales by Country (2017-2022) & (K Units)
Table 54. North America Nucleic Vaccine Sales by Country (2023-2028) & (K Units)
Table 55. North America Nucleic Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Nucleic Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Nucleic Vaccine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Nucleic Vaccine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Nucleic Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Nucleic Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Nucleic Vaccine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Nucleic Vaccine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Nucleic Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Nucleic Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Nucleic Vaccine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Nucleic Vaccine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Nucleic Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Nucleic Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Nucleic Vaccine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Nucleic Vaccine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Nucleic Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Nucleic Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Nucleic Vaccine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Nucleic Vaccine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Nucleic Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Nucleic Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Nucleic Vaccine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Nucleic Vaccine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Nucleic Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Nucleic Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Nucleic Vaccine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Nucleic Vaccine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Nucleic Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Nucleic Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Nucleic Vaccine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Nucleic Vaccine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Nucleic Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Nucleic Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Nucleic Vaccine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Nucleic Vaccine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Nucleic Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Nucleic Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Nucleic Vaccine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Nucleic Vaccine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Nucleic Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Nucleic Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Nucleic Vaccine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Nucleic Vaccine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Nucleic Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Nucleic Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Nucleic Vaccine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Nucleic Vaccine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Nucleic Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Nucleic Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Moderna Corporation Information
Table 106. Moderna Description and Major Businesses
Table 107. Moderna Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Moderna Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Moderna Recent Developments
Table 110. CureVac Corporation Information
Table 111. CureVac Description and Major Businesses
Table 112. CureVac Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. CureVac Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. CureVac Recent Developments
Table 115. Inovio Corporation Information
Table 116. Inovio Description and Major Businesses
Table 117. Inovio Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Inovio Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Inovio Recent Developments
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Sanofi Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Recent Developments
Table 125. GSK Corporation Information
Table 126. GSK Description and Major Businesses
Table 127. GSK Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. GSK Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. GSK Recent Developments
Table 130. CNBG Corporation Information
Table 131. CNBG Description and Major Businesses
Table 132. CNBG Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. CNBG Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. CNBG Recent Developments
Table 135. Hualan Bio Corporation Information
Table 136. Hualan Bio Description and Major Businesses
Table 137. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Hualan Bio Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Hualan Bio Recent Developments
Table 140. Zhifei Shengwu Corporation Information
Table 141. Zhifei Shengwu Description and Major Businesses
Table 142. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 143. Zhifei Shengwu Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Zhifei Shengwu Recent Developments
Table 145. Liaoning Chengda Corporation Information
Table 146. Liaoning Chengda Description and Major Businesses
Table 147. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 148. Liaoning Chengda Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Liaoning Chengda Recent Developments
Table 150. BioKangtai Corporation Information
Table 151. BioKangtai Description and Major Businesses
Table 152. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 153. BioKangtai Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. BioKangtai Recent Developments
Table 155. CanSinoBIO Corporation Information
Table 156. CanSinoBIO Description and Major Businesses
Table 157. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 158. CanSinoBIO Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. CanSinoBIO Recent Developments
Table 160. Walvax Biotechnology Corporation Information
Table 161. Walvax Biotechnology Description and Major Businesses
Table 162. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 163. Walvax Biotechnology Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Walvax Biotechnology Recent Developments
Table 165. Fosun Pharma Corporation Information
Table 166. Fosun Pharma Description and Major Businesses
Table 167. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 168. Fosun Pharma Nucleic Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. Fosun Pharma Recent Developments
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Nucleic Vaccine Distributors List
Table 173. Nucleic Vaccine Customers List
Table 174. Nucleic Vaccine Market Trends
Table 175. Nucleic Vaccine Market Drivers
Table 176. Nucleic Vaccine Market Challenges
Table 177. Nucleic Vaccine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Nucleic Vaccine Product Picture
Figure 3. Global Nucleic Vaccine Market Share by Type in 2021 & 2028
Figure 3. Preventive Nucleic Vaccine Product Picture
Figure 4. Therapeutic Nucleic Vaccine Product Picture
Figure 5. Global Nucleic Vaccine Market Share by Application in 2021 & 2028
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Nucleic Vaccine Report Years Considered
Figure 10. Global Nucleic Vaccine Sales 2017-2028 (K Units)
Figure 11. Global Nucleic Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Nucleic Vaccine Revenue 2017-2028 (US$ Million)
Figure 13. Global Nucleic Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Nucleic Vaccine Sales Market Share by Region (2017-2022)
Figure 15. Global Nucleic Vaccine Sales Market Share by Region (2023-2028)
Figure 16. North America Nucleic Vaccine Sales YoY (2017-2028) & (K Units)
Figure 17. North America Nucleic Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Nucleic Vaccine Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Nucleic Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Nucleic Vaccine Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Nucleic Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Nucleic Vaccine Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Nucleic Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Nucleic Vaccine Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Nucleic Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Nucleic Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Nucleic Vaccine in the World: Market Share by Nucleic Vaccine Revenue in 2021
Figure 28. Global Nucleic Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Nucleic Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Nucleic Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Nucleic Vaccine Sales Market Share by Application (2017-2028)
Figure 32. Global Nucleic Vaccine Revenue Market Share by Application (2017-2028)
Figure 33. North America Nucleic Vaccine Sales Market Share by Type (2017-2028)
Figure 34. North America Nucleic Vaccine Revenue Market Share by Type (2017-2028)
Figure 35. North America Nucleic Vaccine Sales Market Share by Application (2017-2028)
Figure 36. North America Nucleic Vaccine Revenue Market Share by Application (2017-2028)
Figure 37. North America Nucleic Vaccine Sales Share by Country (2017-2028)
Figure 38. North America Nucleic Vaccine Revenue Share by Country (2017-2028)
Figure 39. U.S. Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Nucleic Vaccine Sales Market Share by Type (2017-2028)
Figure 42. Europe Nucleic Vaccine Revenue Market Share by Type (2017-2028)
Figure 43. Europe Nucleic Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Nucleic Vaccine Revenue Market Share by Application (2017-2028)
Figure 45. Europe Nucleic Vaccine Sales Share by Country (2017-2028)
Figure 46. Europe Nucleic Vaccine Revenue Share by Country (2017-2028)
Figure 47. Germany Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. France Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Nucleic Vaccine Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Nucleic Vaccine Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Nucleic Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Nucleic Vaccine Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Nucleic Vaccine Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Nucleic Vaccine Revenue Share by Region (2017-2028)
Figure 58. China Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. India Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Taiwan Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 67. Philippines Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Nucleic Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Latin America Nucleic Vaccine Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Nucleic Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Latin America Nucleic Vaccine Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Nucleic Vaccine Sales Share by Country (2017-2028)
Figure 73. Latin America Nucleic Vaccine Revenue Share by Country (2017-2028)
Figure 74. Mexico Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Nucleic Vaccine Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Nucleic Vaccine Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Nucleic Vaccine Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Nucleic Vaccine Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Nucleic Vaccine Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Nucleic Vaccine Revenue Share by Country (2017-2028)
Figure 83. Turkey Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Nucleic Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. Nucleic Vaccine Value Chain
Figure 87. Nucleic Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
Industry Market Size
